Thromb Haemost 1986; 56(01): 100-106
DOI: 10.1055/s-0038-1661611
Original Article
Schattauer GmbH Stuttgart

Immunologic Identification of the Cleavage Products from the Aα- and Bβ-Chains in the Early Stages of Plasmin Digestion of Fibrinogen

C Y Liu
The Department of Medicine, Columbia University College of Physicians and Surgeons, New York, N.Y., USA
,
Joan H Sobel
The Department of Medicine, Columbia University College of Physicians and Surgeons, New York, N.Y., USA
,
J I Weitz
The Department of Medicine, Columbia University College of Physicians and Surgeons, New York, N.Y., USA
,
Karen L Kaplan
The Department of Medicine, Columbia University College of Physicians and Surgeons, New York, N.Y., USA
,
H L Nossel
The Department of Medicine, Columbia University College of Physicians and Surgeons, New York, N.Y., USA
› Author Affiliations
Further Information

Publication History

Received 14 January 1986

Accepted 12 May 1986

Publication Date:
21 August 2018 (online)

Summary

Fragment X components (Mr 225,000 to 333,000) were distinguished on sodium dodecyl sulfate polyacrylamide gels. Western blotting with monoclonal antibodies to Aα-chain segments demonstrated that the Aα-chains of fibrinogen and the largest fragment X components (Mr 285,000-340,000) contained both Aα 259-276 and Aα 540-554. Fragment X components of Mr 270.000-285,000 contained Aα 259-276 but lacked Aα 540-554, whereas the smallest fragment X components (Mr 225.000-270,000) contained neither Aα 540-554 nor Aα 259-276. Studies of the small peptides generated during fragment X formation complemented the studies of the large molecules, by demonstrating peptides containing both Aα 259-276 and Aα 540-554 (Mr 41,600-41,800 and Mr 38,700-38,900), peptides containing Aα 540-554 but not Aα 259-276 (Mr 20,500-21,000 and Mr 17,300-17,500) and peptides containing only Aα 259-276 (Mr 23,600-24,000 and Mr 20,500-21,000). Cleavage of Bβ 1-42 from the amino terminal ends of the Bβ-chains, measured with a specific radioimmunoassay, was linear until 1.6 moles per mole of fibrinogen had been relased, and coincided with loss of the central and carboxy terminal Aα-chain regions, i. e. Aα 259-276 and Aα 540-554. Based on present and previously reported data, a model is proposed for the evolution of the heterogenous group of fragment X derivatives from fibrinogen with the simultaneous release of small peptides. Features of this model include

1. asymmetric cleavage of the fibrinogen dimer and

2. proteolyses of several different bonds occurring simultaneously but at distinct rates.

 
  • References

  • 1 Marder VJ, Shulman NR, Carroll WR. High molecular weight derivatives of human fibrinogen produced by plasmin: (I) Physicochemical and immunological characterization. J Biol Chem 1969; 244: 2111-2119
  • 2 Marder VJ, Budzynski AZ, James HL. High molecular weight derivatives of human fibrinogen produced by plasmin: (III) Their NH2-terminal amino acids and comparison with the NH2-terminal disulfide knot. J Biol Chem 1972; 247: 4775-4781
  • 3 Mills D. A molecular model for the proteolysis of human fibrinogen by plasmin. Biochem Biophys Acta 1972; 263: 619-630
  • 4 Pizzo SV, Schwartz ML, Hill RL, McKee PA. The effect of plasmin on the subunit structure of human fibrinogen. J Biol Chem 1972; 247: 636-645
  • 5 Mosesson MW, Finalyson JS, Galanakis DK. The essential covalent structure of human fibrinogen evinced by analysis of derivatives formed during plasmic hydrolysis. J Biol Chem 1973; 248: 7913-7929
  • 6 Galanakis DK, Mosesson MW, Stathakis NE. Human fibrinogen heterogeneities: Distribution and charge characteristics of chains of Aα-origin. J Lab Clin Med 1978; 92: 376-386
  • 7 Takagi T, Doolittle RF. Amino acid sequence studies on plasmin-derived fragments of human fibrinogen. Biochem 1975; 14: 940-946
  • 8 Takagi T, Doolittle RF. Amino acid sequence studies on the α-chain of human fibrinogen. Location of four plasmin attack points and a covalent cross-linking site. Biochem 1975; 14: 5149-5156
  • 9 Furlan M, Seelich T, Beck EA. Plasmin degradation of human fibrinogen. Biochem Biophys Acta 1975; 400: 112-120
  • 10 Ferguson EW, Fretto LJ, McKee PA. A reexamination of the cleavage of fibrinogen and fibrin by plasmin. J Biol Chem 1975; 250: 7210-7218
  • 11 Marder VJ, Matchett MO, Sherry S. Detection of serum fibrinogen and fibrin degradation products. Am J Med 1971; 51: 71-82
  • 12 Black JM, Garvey MB. The detection of fibrinogen/fibrin degradation products by means of a new antibody-coated latex particle. J Clin Path 1972; 25: 680-682
  • 13 Lane DA, Preston FE, VanRoss ME, Kakkar VV. Characterization of serum-fibrinogen and fibrin fragments produced during disseminated intravascular coagulation. Brit J Haemat 1978; 40: 609-615
  • 14 Nossel HL, Wasser J, Kaplan KL, LaGamma KS, Yudelman I. Canfield R E. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline. J Clin Invest 1979; 64: 1371-1378
  • 15 Weitz J, Koehn J, Nossel HL, Canfield RE. Development of an antiserum specific for the fibrinogen-derived peptide Bβ 1-42. Blood 1983; 62: 295A
  • 16 Iwanaga S, Wallen P, Grondahl NJ, Henschen A, Blombäck B. On the primary structure of human fibrinogen. Europ J Biochem 1969; 8: 189-199
  • 17 Wallen P. Plasmic degradation of fibrinogen. Scand J Haemat 1971; (Suppl. 13) 3-14
  • 18 Weinstein MJ, Doolittle RE. Differential specificities of thrombin, plasmin and trypsin with regard to synthetic and natural substrates and inhibitors. Biochem Biophys Acta 1972; 258: 577-590
  • 19 Lahiri B, Shainoff JR. Fate of fibrinopeptides in the reaction between human plasmin and fibrinogen. Biochem Biophys Acta 1973; 303: 161-170
  • 20 Hessel B. On the structure of the COOH-terminal part of the α-chain of human fibrinogen. Thromb Res 1975; 7: 75-87
  • 21 Cottrell BA, Doolittle RF. The amino acid sequence of a 27-residue peptide released from the α-chain carboxy-terminus during the plasmin digestion of human fibrinogen. Biochem Biophys Res Common 1976; 71: 754-761
  • 22 Weinstein JM, Deykin D. Low solubiliy fibrinogen examined by twodimensional sodium dodecyl sulfate gel electrophoresis and isoelectric focusing. Thromb Res 1978; 13: 361-377
  • 23 Doolittle RF, Watt KW K, Cottrell BA, Strong DD, Riley M. The amino acid sequence of the α-chain of human fibrinogen. Nature 1979; 280: 464-468
  • 24 Watt KW K, Cottrell BA, Strong DD, Doolittle RF. Amino acid sequence studies on the α-chain of human fibrinogen. Biochem 1979; 18: 5410-5416
  • 25 Ferguson EW J. High-resolution two-dimensional electrophoretic analysis of fibrinogen digestion by plasmin. Lab Clin Med 1980; 96: 710-721
  • 26 Ehrlich PH, Sobel JH, Moustafa ZA, Canfield RE. Monoclonal antibodies to α-chain regions of human fibrinogen that participate in polymer formation. Biochem 1983; 22: 4184-4192
  • 27 Liu CY, Koehn JA, Morgan FJ. Characterization of fibrinogen New York 1. J Biol Chem 1985; 260: 4390-4396
  • 28 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
  • 29 Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitocellulose sheets: Procedure and some applications. Proc Natl Acad Sci (USA) 1979; 76: 4350-4354
  • 30 Burnette W. Western blotting. Anal Biochem 1981; 112: 195-203
  • 31 Nossel HL, Young LR, Wilner GD, Procupez T, Canfield RE, Butler jr VP. Radioimmunoassay of human fibrinopeptide A. Proc Natl Acad Sci (USA) 1971; 68: 2350-2353
  • 32 Bilezikian SB, Nossel HL, Butler Jr VP, Canfield RE. Radioimmunoassay of human fibrinopeptide B and kinetics of fibrinopeptide cleavage by different enzymes. J Clin Invest 1975; 56: 438-445
  • 33 Koehn JA, Canfield RE. Purification of human fibrinopeptides by HPLC. Anal Biochem 1981; 116: 349-356
  • 34 Gaffney PJ, Dobos P. A structural aspect of human fibrinogen suggested by plasmin degradation. FEBS Letters 1971; 15: 13-16